masthead-news

News & Events

2021 ASCO Virtual Scientific Meeting

Visit HTG's customer posters presented at the 2021 ASCO Virtual Scientific Meeting? 

  • Loibl, S., et al. Phase III study of palbociclib combined with endocrine therapy in patients with hormone-receptor-positive, HER2-negative primary breast cancer and high relapse risk after neoadjuvant chemotherapy: First results from PENELOPE-B
  • Lopez-Guerrero, J. A., et al. MamaPred: a new and innovative approach to determine recurrence risk classification in luminal early-stage breast cancer using HTG EdgeSeq Technology.
  • Jaramillo, M., et al. Gene expression profiling signatures for immunophenotyping of tumor microenvironment using HTG EdgeSeq Precision Immuno-Oncology Panel.
Posted on:

Return To List

Page last updated May 03, 2021